During the past decade, U.S. Renal Care conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "U.S. Renal Care" are "Pruritus" (2 trials), "Uremic Pruritus" (2 trials), "Chronic Kidney Disease" (1 trials), "Chronic Kidney Failure" (1 trials) and "Chronic Renal Failure" (1 trials). Many other conditions were trialed in "U.S. Renal Care" in a lesser frequency.

Most popular intervention types in "U.S. Renal Care" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "CTA018 Injection" (1 trials), "Lanthanum carbonate" (1 trials), "Magnesium iron hydroxycarbonate" (1 trials), "Placebo" (1 trials) and "Placebo tablets BID" (1 trials). Other intervention names were less common.

The vast majority of trials in "U.S. Renal Care" are 4 trials for "All" genders.

Currently, there are NaN active trials in "U.S. Renal Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in U.S. Renal Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in U.S. Renal Care, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".